melamine cyanurate profile

melamine cyanurate: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

melamine cyanurate : A crystalline complex formed from a 1:1 mixture of melamine and cyanuric (isocyanuric) acid, held together by an extensive two-dimensional network of hydrogen bonds between the two compounds. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

ID Source	ID
PubMed CID	93198
SCHEMBL ID	34655
MeSH ID	M0195073

Synonym
melamine cyanaurate
37640-57-6
nsc-231587
nsc231587
melamine cyanurate
nsc 231587
melamine isocyanurate
melaminkyanurat [czech]
mitec mx 601
einecs 253-575-7
d 022
AKOS024319632
einecs 240-292-9
16133-31-6
1,3,5-triazine-2,4,6(1h,3h,5h)-trione, compound with 1,3,5-triazine-2,4,6-triamine
ec 253-575-7
melaminkyanurat
FT-0639392
AKOS015901107
SCHEMBL34655
DTXSID3068043
ZQKXQUJXLSSJCH-UHFFFAOYSA-N
melamine cyanuric acid
melamine isocyanuric acid
W-106524
melaminecyanurate
1,3,5-triazinane-2,4,6-trione compound with 1,3,5-triazine-2,4,6-triamine (1:1)
Q3267336
mfcd00137334
AS-12328
1,3,5-triazinane-2,4,6-trione;1,3,5-triazine-2,4,6-triamine
melamine cyanurate (mca)
melamine cyanuric acid adduct

Excerpt	Reference	Relevance
" In conclusion, MC mixture could cause toxic effects in the gastrointestinal tract and liver in mice during acute and sub-acute toxicity study."	( The toxic effect of a mixture of melamine and cyanuric acid on the gastrointestinal tract and liver in mice. Chang, L; She, R; Sun, Y; Yue, Z; Zhu, J, 2015)	0.42

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	0 (0.00)	18.7374
1990's	1 (6.67)	18.2507
2000's	3 (20.00)	29.6817
2010's	11 (73.33)	24.3611
2020's	0 (0.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	1 (6.67%)	6.00%
Case Studies	1 (6.67%)	4.05%
Observational	0 (0.00%)	0.25%
Other	13 (86.67%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Classes	Roles
n-vinyl-2-pyrrolidinone N-vinyl-2-pyrrolidinone: monomer of POVIDONE; structure given in first source	2.08	1	pyrrolidin-2-ones
caprolactam Caprolactam: Cyclic amide of caproic acid used in manufacture of synthetic fibers of the polyamide type. Can cause local irritation.. epsilon-caprolactam : A member of the class of caprolactams that is azepane substituted by an oxo group at position 2.	2.11	1	caprolactams	human blood serum metabolite
melamine melamine: RN given refers to parent cpd; structure. melamine : A trimer of cyanamide, with a 1,3,5-triazine skeleton.	3.46	7	triamino-1,3,5-triazine	xenobiotic metabolite
cyanuric acid cyanuric acid: RN given refers to parent cpd. isocyanuric acid : The keto tautomer of cyanuric acid.. cyanuric acid : The enol tautomer of isocyanuric acid.	3.17	5	1,3,5-triazinanes; 1,3,5-triazines; heteroaryl hydroxy compound	xenobiotic
phosphine phosphane : The simplest phosphine, consisting of a single phosphorus atom with three hydrogens attached.. phosphine : Phosphane (PH3) and compounds derived from it by substituting one, two or three hydrogen atoms by hydrocarbyl groups: RPH2, R2PH, R3P (R =/= H) are called primary, secondary and tertiary phosphines, respectively. A specific phosphine is preferably named as a substituted phosphane.	2.11	1	mononuclear parent hydride; phosphanes; phosphine	carcinogenic agent; fumigant insecticide
phosphites Phosphites: Inorganic salts or organic esters of phosphorous acid that contain the (3-)PO3 radical. (From Grant & Hackh's Chemical Dictionary, 5th ed). phosphite(3-) : A trivalent inorganic anion obtained by removal of all three protons from phosphorous acid.	2.11	1	phosphite ion; trivalent inorganic anion
aluminum Aluminum: A metallic element that has the atomic number 13, atomic symbol Al, and atomic weight 26.98.	2.11	1	boron group element atom; elemental aluminium; metal atom

Condition	Relationship Strength	Studies
Urinary Lithiasis [description not available]	2.1	1
Urolithiasis Formation of stones in any part of the URINARY TRACT, usually in the KIDNEY; URINARY BLADDER; or the URETER.	2.1	1
Kidney Stones [description not available]	2.05	1
Kidney Calculi Stones in the KIDNEY, usually formed in the urine-collecting area of the kidney (KIDNEY PELVIS). Their sizes vary and most contains CALCIUM OXALATE.	2.05	1
Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)	2.05	1
Acute Kidney Failure [description not available]	2.05	1
Acute Kidney Injury Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions.	2.05	1
Nephrolithiasis Formation of stones in the KIDNEY.	2.05	1
Calcification, Pathologic [description not available]	2.05	1
Cat Diseases Diseases of the domestic cat (Felis catus or F. domesticus). This term does not include diseases of the so-called big cats such as CHEETAHS; LIONS; tigers, cougars, panthers, leopards, and other Felidae for which the heading CARNIVORA is used.	2.05	1
Calcinosis Pathologic deposition of calcium salts in tissues.	2.05	1
Hyperparathyroidism A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.	2.05	1
Kidney Diseases Pathological processes of the KIDNEY or its component tissues.	2.05	1
Extravascular Hemolysis [description not available]	2.05	1
Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.	2.05	1
Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.	2.07	1
Kidney Failure A severe irreversible decline in the ability of kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism.	2.07	1
Renal Insufficiency Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage (as measured by the level of PROTEINURIA) and reduction in GLOMERULAR FILTRATION RATE.	2.07	1

melamine cyanurate

Description

Cross-References

Synonyms (33)

Research Excerpts

Toxicity

Research

Studies (15)

Market Indicators

Research Demand Index: 49.66

Study Types